Rutinib Cream (Ruxolitinib INN 1.5%)

Product Name: Rutinib Cream (each tube contains 30mg ruxolitinib INN 1.5%)

Generic Name: Ruxolitinib

Brand Name: Opzelura

Manufacturer: Drug International Ltd.

  • Medically Reviewes by Dr. Daria Kwaśniewska
  • WHO-GMP standards
  • Instant Online Verification

Description

What is Rutinib Cream & who should take it?

Rutinib Cream is prescribed as a targeted Topical Janus Kinase Inhibitor therapy for Atopic Dermatitis and vitiligo. It Contains Ruxolitinib (1.5%), matching the API concentration standard established in dermatological care.

You may consider this if:

  • ​You have been diagnosed with mild-to-moderate atopic dermatitis that has not responded adequately to standard topical prescriptions.
  • You are an adult or adolescent (12+) seeking targeted repigmentation for nonsegmental vitiligo.
  • You are seeking an accessible formulation of topical ruxolitinib managed under clinical guidance.

This may NOT be suitable if:

  • You need to apply treatment to more than 20% of your total body surface area (10% for vitiligo).
  • You have an active, serious localized or systemic infection.

🔬 Quick Clinical Profile

Clinical ParameterData
Active IngredientRuxolitinib (1.5%)
Drug ClassTopical Janus Kinase (JAK) Inhibitor
Standard DosageApply a thin layer to affected areas twice daily
MetabolismHepatic via CYP3A4 (for systemically absorbed fractions)
Half-Life~3 hours (systemic)
Quality StandardProduced in GMP-certified facilities

🧠 How does Rutinib Cream work?

Ruxolitinib is a targeted inhibitor of the Janus kinase (JAK1 and JAK2) pathways. In conditions like atopic dermatitis and vitiligo, the immune system overproduces specific pro-inflammatory cytokines, including interleukin-4 (IL-4), interleukin-13 (IL-13), and interferon-gamma (IFN-γ). By blocking the JAK signaling pathway, ruxolitinib disrupts the production of these cytokines, thereby reducing skin inflammation, severe pruritus (itching), and the localized immune response that drives depigmentation.

👤 Who Typically Gets Prescribed with Rutinib Cream?

This treatment approach aligns with widely used dermatology and immunology practices, including guidance frameworks for targeted topical therapies.
  • Patients aiming to restore skin pigmentation lost to nonsegmental vitiligo.
  • Individuals suffering from chronic atopic dermatitis who require a steroid-sparing treatment option.
  • Patients holding a valid prescription who require access to an accessible formulation of a topical JAK inhibitor.

📅 First 30 Days Experience

Starting a new treatment requires patience and observation. Every patient responds differently, but clinical data suggests a common early pattern when using a topical ruxolitinib formulation.
  • Week 1: Patients with atopic dermatitis frequently report a rapid reduction in severe itching (pruritus) and early calming of erythema (redness).
  • Week 2–3: The skin barrier continues to stabilize. For vitiligo patients, this is a foundational period; immune activity is suppressed, though visible repigmentation typically takes much longer to appear.
  • Week 4: Continued clearance of dermatitis lesions. Patients establish a routine, understanding the precise application volume required for their affected areas.

⚠️ Call your doctor immediately if you experience:

  • Signs of a worsening skin infection (severe warmth, oozing, or worsening pain at the application site).
  • Unexpected systemic symptoms, such as an unexplained fever, chills, or extreme fatigue.

⚠️ Side Effects

Common & Manageable:

  • Mild redness
  • Acneiform eruptions
  • Stinging
  • Nasopharyngitis
  • Minor headaches

Less Common but Serious:

  • serious infections
  • changes in blood counts
These effects are commonly reported in patients taking topical ruxolitinib and are usually manageable with early medical guidance. Always tell your care team how you are feeling.

💰 How much does Rutinib Cream Costs & how to source it?

Dermatological treatment is often continuous, securing a sustainable supply of ruxolitinib can help manage long-term care logistics. As an international medical sourcing platform, we prioritize supply chain integrity. Rutinib Cream is manufactured in WHO-GMP certified plant maintaining the global standard to ensure top quality standard. Global shipments are handled according to standard pharmaceutical distribution practices, utilizing appropriate thermal packaging protocols (if necessary) to maintain product stability during transit.

📊 Clinical Evidence and Comparison

Clinical efficacy for 1.5% topical ruxolitinib is established through robust trials, including the TRuE-V1/TRuE-V2 trials for vitiligo (showing significant F-VASI75 repigmentation at 24-52 weeks) and the TRuE-AD trials for atopic dermatitis.
FeatureRuxolitinib 1.5% (Rutinib / Opzelura)Topical CorticosteroidsTopical Calcineurin Inhibitors (Tacrolimus)
MechanismTargeted JAK1/JAK2 InhibitorBroad ImmunosuppressionCalcineurin Pathway Inhibitor
Skin Thinning RiskLow/NoneHigh (with long-term use)Low/None
Application Site StingingLowLowModerate to High

🍽️ How to use Rutinib Cream?

  • Wash your hands thoroughly before and after use.
  • Apply a thin layer of the cream directly to the affected skin areas twice a day.
  • Do not use more than 60 grams per week, and do not apply it to large areas of the body (staying under 20% of your body surface area for eczema, and 10% for vitiligo).
  • This product is for external use only; avoid contact with your eyes, mouth, and any open wounds.

👨‍👩‍👧 What caregivers tells you to monitor?

As it is first time for a patient, they may rely heavily on their caregivers during the first few weeks of managing complex skin conditions.
  • Assist with application: Help the patient apply the cream to hard-to-reach affected areas, ensuring only a thin layer is used.
  • Track the dosage: Monitor the tube usage to ensure the patient does not exceed the strict 60-gram weekly limit.
  • Monitor the skin: Check the application sites daily for any signs of worsening redness, swelling, or potential bacterial infection.

🔄 What should I do if Rutinib Cream does not work?

If your clinical response plateaus or if your skin condition stops improving after several months, your dermatologist may reassess your treatment strategy. Clinical guidelines often suggest exploring combination therapies or alternative modalities if maximum benefit has been reached.

❓ FAQs (Frequently Asked Questions about Rutinib Cream)

How quickly does Ruxolitinib start working?

For atopic dermatitis, ruxolitinib therapy often reduces itching within a few days, while vitiligo repigmentation is a slower process that can take up to 24 weeks to become highly visible.

This depends heavily on your condition; it may be used for short-term clearing of eczema flare-ups, or for continuous long-term management in vitiligo.

You should always consult your dermatologist before stopping, as abruptly discontinuing treatment for chronic conditions can sometimes lead to a return of symptoms.

Generally yes, but you must avoid applying other medicated creams or lotions to the exact same areas of skin at the same time without strict approval from your physician.

A 30-gram tube generally ranges from $100 to $150 USD, subject to regional shipping and government-imposed import taxes. To order this prescription-only medicine, you must provide a valid doctor’s prescription and comply with your country’s Named Patient Program (NPP) import regulations.

This information is intended for educational purposes and should not replace medical advice from your treating physician.

🛒 Ready for the next step?

  • [Check current global availability and secure shipping quotes]
  • [Upload your prescription for an immediate clinical review]
  • [Request transparent, wholesale pricing details today]

Reviews

There are no reviews yet.

Be the first to review “Rutinib Cream (Ruxolitinib INN 1.5%)”

You may also like…